Today political leaders at the #UNGA are to ratify a declaration on Antimicrobial Resistance (AMR) which recognises it as a critical global health and development challenge, with the High-Level Meeting discussing the necessary steps to combat it.
Airfinity’s forecasting on the R&D landscape, which has been published by the IFPMA, shows how the pipeline of new antibiotics will take shape in the next 10 years based on future funding and investment scenarios. It shows that the antibiotic pipeline could decline to only 26 in clinical development with no new investment, with introduction of appropriate targeted incentives boosting this to over 70 by 2034. Read the full report here.
Earlier this year Airfinity hosted an industry round table discussing the global burden of #AMR, forecasting growing resistance to critical priority bacteria and key approaches to stop superbugs spreading. You can watch the discussion on Youtube, the link is in the comments below.
https://lnkd.in/erYCpTvf